CNEN

Welcome to Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.!

Search

Copyright:  Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.!   京ICP备19006400号-1​     Powered by 300.cn

美科

Links:

Stemedica mesenchymal stem cells were approved and listed by Ministry of Health of Kazakhstan as a treatment of acute myocardial infarction.

Source:
Release time:
2018/09/12 16:32
Page view

用Stemedica干细胞治疗急性心梗获得哈萨克斯坦卫生部批准上市。